“You’d be surprised if that child knows that there’s a firearm on that shelf in the closet, they are going to find a way to ...

Four teams from the Northeast Region of the HOPE Animal-Assisted Crisis Response organization were recently called to ...

Rigel Resource Acquisition Corp (RRAC) recently announced the postponement of its extraordinary general meeting scheduled for February 13, 2025. The meeting has been rescheduled to February 28, 2025, ...

Singapore-based Rigel Capital is set to announce the final close of its first early-stage fund, Rigel Star, at slightly over $40 million soon, pushing the total capital the firm has raised across its ...

SOUTH SAN FRANCISCO, Calif., Jan. 22, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the first patient has been enrolled in a Phase 1 study evaluating the safety ...

The mean of analysts' price targets for Rigel (RIGL) points to a 40.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts ...

Shares of Rigel Pharmaceuticals (RIGL) have gained 24.6% over the past four weeks to close the last trading session at $21.65, but there could still be a solid upside left in the stock if short ...

Implementing environmental, social, and governance (ESG) practices has become a non-negotiable prerequisite for any business ...

David A. Santos, Executive Vice President and Chief Commercial Officer at Rigel Pharmaceuticals Inc. (NASDAQ:RIGL), recently sold a portion of his holdings in the company. According to a recent SEC ...

In the press release titled “Rigel Provides Business Update and 2025 Outlook,” Rigel Pharmaceuticals shared some significant financial highlights. For the fourth quarter of 2024, the company ...

Rigel Pharmaceuticals (RIGL) closed the last trading session at $17.35, gaining 0.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set ...